ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
Dow Jones
42.706,56
-0,06%
Euro vs US Dollar
1,03915
0,84%
Bitcoin
102.104,04
3,84%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. ImmunoPrecise Antibodies Ltd (IPA) Börsenkurse

ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd (IPA)

ImmunoPrecise Antibodies Ltd
6,50
0,00
(0,00%)
Geschlossen 06 Januar 10:00PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
6,50
Gebot
6,31
Fragen
6,75
Volumen
-
0,00 Tagesbereich 0,00
6,50 52-Wochen-Bereich 6,50
Marktkapitalisierung
175,136M
Handelsende
6,50
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
26.944.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,54
Gewinn pro Aktie (EPS)
-1,01
Erlöse
24,52M
Nettogewinn
-27,18M

Über ImmunoPrecise Antibodies Ltd

Sektor
Pharmaceutical Preparations
Branche
Miscellaneous Metal Ores,nec
Website
www.immunoprecise.com
Hauptsitz
Victoria, British Columbia, Can
Gegründet
2016
ImmunoPrecise Antibodies Ltd is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker IPA. The last closing price for ImmunoPrecise Antibodies was $6,50. Over the last year, ImmunoPrecise Antibodies shares have traded in a share price range of $ 6,50 to $ 6,50.

ImmunoPrecise Antibodies currently has 26.944.000 shares in issue. The market capitalisation of ImmunoPrecise Antibodies is $175,14 million. ImmunoPrecise Antibodies has a price to earnings ratio (PE ratio) of -0.54.

IPA Neueste Nachrichten

Weitere Nachrichten

IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant

IPA's Subsidiary BioStrand Secures Second VLAIO Research GrantIPA subsidiary BioStrand receives grant to expand LENSai platform by linking HYFTs™ with 3D protein structure and...

09 Mai 2022
InvestorsHub NewsWire

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and...

14 April 2022
InvestorsHub NewsWire

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence New Platform...

29 März 2022
InvestorsHub NewsWire

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

                   IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of...

14 März 2022
InvestorsHub NewsWire

IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03

 IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03 In vivo, IND enabling evaluations of PolyTope® TATX-03 in animal model show:There were no...

09 März 2022
InvestorsHub NewsWire

ImmunoPrecise lance le programme d'anticorps candidat TATX-112 pour le traitement du cancer et de la maladie d'Alzheimer

Traitement potentiel de la maladie de Parkinson et d'autres affections neurodégénératives IMMUNOPRECISE ANTIBODIES LTD. (la "Société" ou "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) un chef de file...

09 April 2021
Business Wire

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease

   ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease   Potential to Treat Parkinson's and Other...

08 April 2021
InvestorsHub NewsWire

ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease

Potential to Treat Parkinson’s and Other Neurodegenerative Diseases IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic...

08 April 2021
Business Wire

ImmunoPrecise identifie un anticorps unique, le 23-H7, qui démontre une efficacité in vivo, un mécanisme d'action alternat...

L'anticorps bloque l'interaction de liaison DFR/ACE2 par le biais d'un mécanisme d'action alternatif L'anticorps se lie à tous les variants préoccupants testés, probablement parce qu'il cible un...

25 März 2021
Business Wire

ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action & B...

Blocks the RBD/ACE2 binding interaction indirectly through an alternative mechanism of action Binds to all tested variants of concern, likely because it targets a site other than the mutation...

25 März 2021
Business Wire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1006.56.56.500CS
4006.56.56.500CS
12006.56.56.500CS
26006.56.56.500CS
52006.56.56.500CS
156-1.14-14.92146596867.648.444.5259336.34183901CS
2605.961103.70370370.5426.250.51727624.07959812CS

IPA - Frequently Asked Questions (FAQ)

What is the current ImmunoPrecise Antibodies share price?
The current share price of ImmunoPrecise Antibodies is $ 6,50
How many ImmunoPrecise Antibodies shares are in issue?
ImmunoPrecise Antibodies has 26.944.000 shares in issue
What is the market cap of ImmunoPrecise Antibodies?
The market capitalisation of ImmunoPrecise Antibodies is CAD 175,14M
What is the 1 year trading range for ImmunoPrecise Antibodies share price?
ImmunoPrecise Antibodies has traded in the range of $ 6,50 to $ 6,50 during the past year
What is the PE ratio of ImmunoPrecise Antibodies?
The price to earnings ratio of ImmunoPrecise Antibodies is -0,54
What is the cash to sales ratio of ImmunoPrecise Antibodies?
The cash to sales ratio of ImmunoPrecise Antibodies is 0,59
What is the reporting currency for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies reports financial results in CAD
What is the latest annual turnover for ImmunoPrecise Antibodies?
The latest annual turnover of ImmunoPrecise Antibodies is CAD 24,52M
What is the latest annual profit for ImmunoPrecise Antibodies?
The latest annual profit of ImmunoPrecise Antibodies is CAD -27,18M
What is the registered address of ImmunoPrecise Antibodies?
The registered address for ImmunoPrecise Antibodies is 3204 - 4464 MARKHAM STREET, VICTORIA, BRITISH COLUMBIA, V8Z 7X8
What is the ImmunoPrecise Antibodies website address?
The website address for ImmunoPrecise Antibodies is www.immunoprecise.com
Which industry sector does ImmunoPrecise Antibodies operate in?
ImmunoPrecise Antibodies operates in the MISCELLANEOUS METAL ORES,NEC sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FINV.PFaction Investment Group Corp
$ 0,05
(233,33%)
17k
ADG.HArcus Development Group Inc
$ 0,015
(200,00%)
10k
AZC.PA2ZCryptocap Inc
$ 0,095
(171,43%)
1,01k
CBAChampion Bear Resources Ltd
$ 0,035
(133,33%)
9k
XBOTRealbotix Corp
$ 0,56
(124,00%)
7,15M
MSPMinaean SP Construction Corp
$ 0,005
(-66,67%)
7k
MUST.HMust Capital Inc
$ 0,025
(-58,33%)
215k
CART.HCarcetti Capital Corp
$ 0,13
(-51,85%)
4,5k
NICKNickelex Resource Corporation
$ 0,005
(-50,00%)
300k
IDIdentillect Technologies Corp
$ 0,005
(-50,00%)
425k
GPUSAlset AI Ventures Inc
$ 0,21
(31,25%)
10,69M
MATEBlockmate Ventures Inc
$ 0,375
(-8,54%)
7,24M
XBOTRealbotix Corp
$ 0,56
(124,00%)
7,15M
QNCQuantum Emotion Corp
$ 1,76
(21,38%)
6,09M
AECAnfield Energy Inc
$ 0,095
(5,56%)
3,84M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
IPA
ImmunoPrecise Antibodies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten